close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Arialys Therapeutics

News headline image
Arialys Therapeutics Announces U.S. FDA Fast Track Designation for ART5803, the First Precision Therapeutic Candidate in Development for the Treatment of Anti-NMDA Receptor Encephalitis
From Arialys Therapeutics
Via Business Wire
News headline image
Arialys Therapeutics Announces First ANRE Patient Treated with ART5803 in Open-Label Phase 2 Study and FDA Clearance of IND for Randomized Phase 2 Study
From Arialys Therapeutics
Via Business Wire
News headline image
Arialys Therapeutics Receives FDA Rare Pediatric Disease Designation for ART5803 to Treat Anti-NMDA Receptor Encephalitis
From Arialys Therapeutics
Via Business Wire
News headline image
Arialys Therapeutics Publishes Preclinical Data in Nature Communications Supporting ART5803 as a First-in-Class Precision Therapeutic for Anti-NMDA Receptor Autoimmune Neuropsychiatric Disease
From Arialys Therapeutics
Via Business Wire
News headline image
Arialys Therapeutics Initiates MAD Cohorts Having Completed All Planned SAD Cohorts in a Phase 1 Study of ART5803 for the Treatment of Autoimmune Neuropsychiatric Disease
From Arialys Therapeutics
Via Business Wire
News headline image
Arialys Therapeutics Appoints Sankalp Gokhale, M.D., Chief Medical Officer
From Arialys Therapeutics
Via Business Wire
News headline image
Arialys Therapeutics Announces First Participants Dosed in a Phase 1 Clinical Trial of ART5803, a Precision Medicine for the Treatment of Autoimmune Neuropsychiatric Diseases
From Arialys Therapeutics
Via Business Wire
News headline image
Arialys Therapeutics Appoints Peter Flynn, Ph.D., President and Chief Executive Officer
From Arialys Therapeutics
Via Business Wire
News headline image
Arialys Therapeutics Launches to Lead the Development of New Precision Medicines for Autoimmune Neuropsychiatric Diseases
From Arialys Therapeutics
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at /week.